Welcome to our dedicated page for Boqii Holding SEC filings (Ticker: BQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Boqii Holding Limited files foreign-issuer reports that document governance, shareholder voting matters, operating updates and capital-structure events for its China pet-products platform. The company’s Form 6-K reports include annual general meeting notices and proxy materials, officer changes, financial-results releases, material agreements, and NYSE American market-action statements.
Its filings also record securities transactions and security-structure changes, including a registered direct offering of Class A ordinary shares and pre-funded warrants, the termination of the ADS facility, substitution listing of Class A ordinary shares, reverse stock split, and amendments to its Cayman Islands constitutional documents. Other disclosures address VIE-related arrangements involving Shanghai Guangcheng and Nanjing Xingmu, incorporation by reference into Form F-3 registration statements, and related foreign-private-issuer reporting matters.
Boqii Holding Limited (ticker: BQ) filed Amendment No. 4 to its Form F-1 registration statement with the SEC on 26 June 2025. This is an exhibits-only amendment; no changes were made to the prospectus or financial disclosures. The filing solely adds or updates the exhibit index, Item 8(a) of Part II, the signature pages and related consents.
The amendment lists 30+ exhibits, including the company’s Thirteenth Amended & Restated Memorandum and Articles of Association, various deposit agreements, PRC legal opinions, share plans, VIE contractual agreements and a series of securities purchase agreements dated 2023 and 2025. A newly filed Exhibit 23.1 provides the consent of Assentsure PAC, the independent registered public accounting firm. All other exhibits were previously filed.
The document reconfirms that Boqii is an emerging growth company incorporated in the Cayman Islands and plans to commence the public offering “as soon as practicable” after effectiveness. Signatures were provided by Co-CEOs Hao Liang and Yingzhi (Lisa) Tang, with Cogency Global Inc. acting as the authorised U.S. representative.